Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Etanercept

🥰Excellent
Catalog No. T37445Cas No. 185243-69-0

Etanercept is a fusion protein consisting of the soluble portion of the p75-tumor necrosis factor receptor (TNFR) and the Fc fragment of human IgG1 and is commonly used to treat patients with rheumatoid arthritis.[1]

Etanercept

Etanercept

🥰Excellent
Purity: 98%
Catalog No. T37445Cas No. 185243-69-0
Etanercept is a fusion protein consisting of the soluble portion of the p75-tumor necrosis factor receptor (TNFR) and the Fc fragment of human IgG1 and is commonly used to treat patients with rheumatoid arthritis.[1]
Pack SizePriceAvailabilityQuantity
1 mg$328In Stock
5 mg$663In Stock
10 mg$995In Stock
25 mg$1,470In Stock
50 mg$1,990In Stock
100 mg$2,680In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Concentration:47.7 mg/mL
Purity:98%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Etanercept is a fusion protein consisting of the soluble portion of the p75-tumor necrosis factor receptor (TNFR) and the Fc fragment of human IgG1 and is commonly used to treat patients with rheumatoid arthritis.[1]
In vitro
METHODS: CHLA-255 cells were co-cultured with human monocytes and treated with etanercept (10 μg/mL). TNF-α levels in the co-culture supernatant were measured by TNF-α ELISA; supernatant IL-6 levels were measured by ELISA.
RESULTS Treatment of NB-monocyte co-cultures with etanercept blocked almost all sTNF-α and IL-6 production.
Etanercept effectively disrupted the pro-tumorigenic mTNF-α/TNFR2 signaling axis between NB cells and monocytes, preventing NF-κB activation in both cell types. This reduced monocyte pro-tumorigenic cytokine production, ultimately leading to increased apoptosis and decreased proliferation of NB cells in vitro. [1]
In vivo
METHODS: Tumor-bearing mice were injected intraperitoneally with etanercept (5 mg/kg) twice a week. Tumor growth was measured by bioluminescence imaging.
RESULTS Etanercept treatment reduced tumor growth by 30% (p<0.05). [1]
METHODS: Etanercept (10 mg/kg/3 days, subcutaneous injection) or saline was administered in AIA rats for 3 weeks at the first signs of arthritis. Body weight and arthritis scores were monitored daily.
RESULTS Etanercept significantly reduced arthritis scores (P < 0.001). [2]
Chemical Properties
Cas No.185243-69-0
Storage & Solubility Information
Storagestore at low temperature | store at -80°C | Shipping with blue ice.
Solubility Information
DMSO: Soluble

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Etanercept | purchase Etanercept | Etanercept cost | order Etanercept | Etanercept chemical structure | Etanercept in vivo | Etanercept in vitro